GSK3145095
Product Specifications
UNSPSC Description
GSK3145095 is a RIP1 kinase inhibitor with an IC50 of 6.3 nM [1].
Target Antigen
RIP kinase
Type
Reference compound
Related Pathways
Apoptosis
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/gsk3145095.html
Purity
99.39
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
FC1=CC(F)=CC2=C1NC([C@@H](NC(C3=NNC(CC4=CC=CC=C4)=N3)=O)CC2)=O
Molecular Weight
397.38
References & Citations
[1]Harris PA, ET AL. Identification of a RIP1 Kinase Inhibitor Clinical Candidate (GSK3145095) for the Treatment of Pancreatic Cancer. ACS Med Chem Lett. 2019 May 9;10(6):857-862.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-111946/GSK3145095-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-111946/GSK3145095-SDS-MedChemExpress.pdf
Clinical Information
Phase 2
CAS Number
1622849-43-7
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1074983-01 0.02 mg (E-Coli)
Recombinant Vaccinia virus Kelch repeat protein F3 (MVA031L, ACAM3000_MVA_031)
Ask
View Details MBS1074983-02 0.02 mg (Yeast)
Recombinant Vaccinia virus Kelch repeat protein F3 (MVA031L, ACAM3000_MVA_031)
Ask
View Details MBS1074983-03 0.1 mg (E-Coli)
Recombinant Vaccinia virus Kelch repeat protein F3 (MVA031L, ACAM3000_MVA_031)
Ask
View Details